Characteristic | Data |
Sex | |
Male | 23 (85.2%) |
Female | 4 (14.8%) |
Median age at diagnosis (y) | 68 (range, 51–82) |
IMIG/IASLC stage (if applicable) | |
2 | 3 (11.1%) |
3 | 8 (29.6%) |
4 | 16 (59.3%) |
Histologic subtype | |
Epitheloid | 21 (77.8%) |
Sarcomatoid | 3 (11.1%) |
Biphasic | 2 (7.4%) |
Desmoplastic | 1 (3.7%) |
Prior lines of chemotherapy | |
2 | 13 (48.1%) |
3 | 8 (29.6%) |
≥4 | 6 (22.2%) |
PD-L1 expression | |
0% | 12 (44.4%) |
1%–49% | 11 (40.7%) |
50%–100% | 3 (11.1%) |
Missing | 1 (3.7%) |
IMIG/IASLC = International Mesothelioma Interest Group/International Association for the Study of Lung Cancer.
Data are n followed by percentage in parentheses, except for age.